Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate Effects of Lipid-Based vs Non-Lipid Artificial Tears on Corneal Aberrations
NCT06784661Phase 4Completed
- Sponsor
- University of Seville
- Start
- Feb 2025
- Primary completion
- Mar 2025
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of mineral oil and hydroxypropyl-guar in corneal wavefront aberration (2 arms), sponsored by University of Seville. Primary endpoint: Changes in Corneal Higher-Order Aberrations at 15 minutes. Started Feb 2025; status: completed.
02
Drugs
mineral oilhydroxypropyl-guar
03
Conditions
corneal wavefront aberration
Beyond the preview
Go deeper on NCT06784661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06784661.